Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Regulatory News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.425
Bid: 0.40
Ask: 0.45
Change: 0.00 (0.00%)
Spread: 0.05 (12.50%)
Open: 0.425
High: 0.425
Low: 0.425
Prev. Close: 0.425
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

South African Power Purchase Agreement

2 Sep 2013 07:00

RNS Number : 9258M
Ultima Networks PLC
02 September 2013
 



2 September 2013

Ultima Networks plc

("Ultima" or the "Company")

5 Year Power Purchase Agreement signed with the Visitor centre at Pilansberg Game Reserve South Africa based upon the Company's Oasis Containerised Hybrid Solar Power Station

The Board of Ultima is pleased to announce that the Company's Green Technology Division has signed an agreement to provide solar electricity to the visitor centre at the Pilansberg Game Reserve in South Africa ('Pilansberg').

Electricity will be generated by installing the Company's Oasis containerised Hybrid Solar Power station ('Oasis'). Oasis is a compact, quick to deploy and scalable solar power station that is capable of providing green energy for applications in the range between 20Kw and 200KW. Each 20KW power pack is incorporated into a 20 foot ISO container and delivered to the required site as a 'ready to use' power station. Oasis is also capable of redeployment to a different site within 48 hours. Oasis has already been supplied to The Kingdom of Saudi Arabia where it is due to go into operation in early September 2013.

Ultima is confident that following the successful deployment of Oasis at Pilansberg, additional business will follow from within the Pilansberg Reserve and other reserves in South Africa. Electricity used at Pilansberg is currently provided by diesel generators due to there being no connection to the electricity grid. The Company's hybrid power station will provide clean renewable energy and will reduce the running time of generators by around 90%. The prestigious visitor centre is used by all who come to this popular game reserve.

The agreement is for a period of 5 years during which the game reserve will purchase the electricity generated by the solar solution. The agreement is renewable beyond the 5 year period at the option of the game reserve. The hybrid solar power station will help to substantially reduce Co2 emissions and eliminate the noise pollution from the generators, thereby reducing the environmental impact of this spectacular location.

Humayun Mughal CEO of Ultima, said:

"The signing of the power purchase agreement represents another step forward in the company's strategy of providing flexible renewable power solutions to a wider market. We are very pleased to have entered into agreement with the visitor centre at Pilansberg Game Reserve and to be associated with the provision of green energy within an area of significant environmental importance. This is the first deployment of a solar solution of this type in a games reserve and we expect many other sites to follow this example."

Enquiries:

Ultima Networks plc

Prof. Humayun Mughal 01279 821 200

 

Zeus Capital Limited (Nominated Adviser and Broker)

Nick Cowles

Tim Metcalfe

 

 

0161 831 1512

020 7533 7727

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGMGFRVGFGFZM
Date   Source Headline
28th Jun 20247:00 amRNSTotal Voting Rights
19th Jun 20247:00 amRNSHolding(s) in Company
18th Jun 202412:34 pmRNSHolding(s) in Company
13th Jun 20244:52 pmRNSHolding(s) in Company
11th Jun 202411:16 amRNSNew Corporate Presentation
7th Jun 202410:18 amRNSPlacing and Subscription to raise £630,000
23rd May 20244:09 pmRNSHolding(s) in Company
23rd May 202412:19 pmRNSResult of AGM
29th Apr 202410:59 amRNSPosting of Annual Report & Notice of AGM
26th Apr 20247:00 amRNSN4 Pharma Webinar on SRI Collaboration
25th Apr 20247:38 amRNSCollaboration Agreement with SRI International Inc
23rd Apr 20247:00 amRNSFinal Results
18th Apr 20247:00 amRNSOral Delivery Update
4th Mar 20243:13 pmRNSHolding(s) in Company
29th Feb 20247:00 amRNSHolding(s) in Company
15th Feb 20247:00 amRNSin-vitro siRNA update
19th Jan 20247:00 amRNSPatent Grant
18th Jan 202410:15 amRNSHolding(s) in Company
16th Jan 20247:00 amRNSNanogenics Update
8th Jan 20244:24 pmRNSHolding(s) in Company
8th Jan 20247:00 amRNSAAV Viral Vector Update
18th Dec 20237:00 amRNSOral Delivery Update
7th Dec 202311:28 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSNuvec® R&D and Strategy Update
30th Nov 20239:00 amRNSN4 Pharma Launches New Interactive Investor Hub
31st Oct 20237:00 amRNSTotal Voting Rights
9th Oct 20237:00 amRNSInvestor Presentation via Investor Meet Company
3rd Oct 20238:15 amRNSHolding(s) in Company
2nd Oct 20237:00 amRNSInvestor Presentation
28th Sep 20237:00 amRNSAcquisition of Controlling Interest in Nanogenics
12th Sep 20237:00 amRNSInterim Results
25th Jul 20237:00 amRNSPatent Grant and Board Change
27th Jun 20237:00 amRNSGrant Award for Professor Chengzhong Yu
25th Apr 20237:00 amRNSsiRNA update
18th Apr 20237:00 amRNSsiRNA update
3rd Apr 20232:11 pmRNSResult of AGM
9th Mar 20237:00 amRNSPosting of Annual Report & Notice of AGM
9th Mar 20237:00 amRNSFinal Results
14th Feb 20234:40 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
17th Jan 20232:05 pmRNSSecond Price Monitoring Extn
17th Jan 20232:00 pmRNSPrice Monitoring Extension
17th Jan 202311:05 amRNSSecond Price Monitoring Extn
17th Jan 202311:00 amRNSPrice Monitoring Extension
17th Jan 20239:05 amRNSSecond Price Monitoring Extn
17th Jan 20239:00 amRNSPrice Monitoring Extension
17th Jan 20237:00 amRNSOral application update
30th Nov 20225:28 pmRNSHolding(s) in Company
30th Nov 20227:00 amRNSTotal Voting Rights
25th Nov 20222:49 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.